Chris is Professor of Molecular Cardiology in Swansea University Medical School. His group uses molecular and cellular tools combined with network theory to explore the links between calcium signaling, cellular behavior and the early events leading to the destruction of normal heart rhythm (arrhythmia).
Chris’ primary research focus is on using experimental and clinical data to predict how heart cells, the engine of every heartbeat, respond to genetic mutations and to drugs. His work will improve therapeutic approaches for tackling genetic and acquired heart disease. His research is funded by the British Heart Foundation, BBSRC, Wellcome Trust, MRC, Health and Care Research Wales and the European Union.
Chris is Senior Editor at the British Journal of Pharmacology looking after the Journal’s cardiovascular portfolio. He is also a member of the editorial board of Cardiovascular Research, Frontiers in Physiology and Artery Research.
He is on the Board of the National Centre for Replacement, Refinement and Reduction of Animals in Research (NC3Rs) and is Chair of its Grant Assessment Panel.
In 2020, Chris became the Chair of the National Cardiovascular Network for Wales (NCN), a partnership between Welsh Government and the British Heart Foundation.
Any spare time he has is completely dominated by the tapestry of family life. In 1973, Chris began a lifelong love-affair with Liverpool Football Club and he plays a variety of guitars less well than anyone he lives with. He is a huge fan of the great outdoors, walking and cycling.